Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Advanced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Jaideep Patel is a Cardiologist in Baltimore, Maryland. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, and Heart Failure.

Tala K Al-Talib, M.D. is a cardiologist in Baltimore, MD. She is the Medical Director of Johns Hopkins Medicine – Cardiology at Johns Hopkins Greenspring Station. Dr. Al-Talib’s clinical areas of focus are in general and preventative cardiology. She specializes in cardiovascular disease in women, with a particular interest in cardiovascular risk assessment and treatment of cardiac conditions in women with breast cancer or other oncological history. She was integral in the establishment of the Preventative Cardiology Program to Improve Heart Health for Female Breast Cancer Survivors, a collaborative effort to detect asymptomatic cardiovascular disease and ultimately prevent cardiovascular events in this patient group. After receiving her medical degree from University of Maryland School of Medicine, Dr. Al-Talib completed her residency in Internal Medicine at the University of Maryland Medical Center, where she was Chief Medical Resident. She completed her post-doctoral fellowship in cardiovascular medicine at University of Maryland Medical Center. In addition to her clinical practice, Dr. Al-Talib also serves as an inpatient echocardiographer at Bayview Medical Center, performing transesophageal echo (TEE) and cardioversions and attends on the inpatient cardiology services. Videos Red Chair SeriesDr. Tala Al-Talib. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Heart Attack, Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, and Apoplexy.

Dr. Elizabeth Ratchford is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include vascular medicine. Dr. Ratchford serves as the director of the Johns Hopkins Center for Vascular Medicine. Dr. Ratchford received her M.D. from the Yale University School of Medicine. She completed her residency at New York-Presbyterian Hospital/Columbia University. Her research interests include peripheral artery disease, fibromuscular dysplasia, and cardiovascular disease prevention among firefighters. Dr. Ratchford has been recognized by several honors, including the Merck Book Award from Yale University School of Medicine. She serves on the editorial board of the journal Vascular Medicine as editor of the Patient Page Section. She is currently the President of the Society for Vascular Medicine. Dr. Ratchford is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Superficial Thrombophlebitis, Carotid Artery Disease, Peripheral Artery Disease, and Deep Vein Thrombosis.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as an Advanced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Thomas Guarnieri is a Cardiologist in Towson,, Maryland. Dr. Guarnieri is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Inappropriate Sinus Tachycardia (IST), Familial Ventricular Tachycardia, Atrial Fibrillation, and Arrhythmias.

James Porterfield is a Cardiologist in Towson,, Maryland. Dr. Porterfield is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Atrial Fibrillation, and Angina.

Daniel Plotnick is a Cardiologist in Towson, Maryland. Dr. Plotnick is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Apoplexy, Aortic Regurgitation, Atrial Fibrillation, and Cardiomyopathy.

Nicole Minkove is a Cardiologist in Towson,, Maryland. Dr. Minkove is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Giant Cell Myocarditis, and Cardiomyopathy.

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Ronald Schechter is a Cardiologist in Towson, Maryland. Dr. Schechter is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Cardiomyopathy, Necrosis, Atherosclerosis, and Coronary Heart Disease.

Duncan Salmon is a Cardiologist in Towson, Maryland. Dr. Salmon is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Angina, Atherosclerosis, Coronary Heart Disease, and Hypertension.

Sunal Makadia is a Cardiologist in Baltimore,, Maryland. Dr. Makadia is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Familial Dilated Cardiomyopathy, and Angina.

Brad Pfeffer is a Cardiologist in Baltimore,, Maryland. Dr. Pfeffer is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Ambereen Quraishi is a Cardiologist in Pikesville,, Maryland. Dr. Quraishi is rated as an Advanced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Atrial Fibrillation, Wolff-Parkinson-White Syndrome, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Julianna Czum’s primary focus is cardiothoracic imaging, with clinical subspecialties in noninvasive cardiovascular and thoracic imaging. Dr. Czum earned her medical degree from UMDNJ - Robert Wood Johnson Medical School before going on to an internship at Mary Imogene Bassett Hospital and residency at St. Barnabas Medical Center. She completed a fellowship in cardiovascular magnetic resonance in a combined Henry Jackson Foundation-funded program at the National Institutes of Health, National Naval Medical Center and Uniformed Services University of the Health Sciences. Dr. Czum joined the diagnostic faculty in June 2022. Dr. Czum is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. Her top areas of expertise are Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Chronic Cough, and Lung Nodules.

Dr. Michael Kelemen is a general cardiologist for the Johns Hopkins Heart and Vascular Institute in the Department of Medicine. His research in cardiac rehabilitation demonstrated the power of exercise as a treatment for hypertension, high cholesterol, and recovery from cardiac events. Dr. Kelemen is an associate professor of medicine in the Johns Hopkins School of Medicine. Dr. Kelemen received his medical degree from the University of Pennsylvania Health System School of Medicine. He completed his residency in medicine at University Hospitals of Cleveland, and pursued cardiology fellowships at the University of California, San Francisco School of Medicine and at the Wyman Park Health System in Baltimore. Dr. Kelemen is active in community health issues, having served on the boards of the Health Alliance and The Horizon Foundation, which provide medical and mental health services to underserved populations. As the founding medical director of the Prescribed Active Cardiac Exercises (PACE) program at Catonsville Community College in 1976, he performed the research that demonstrated the benefits of exercise for cardiac patients. Dr. Kelemen is rated as an Experienced provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Heart Attack, Apoplexy, Postural Orthostatic Tachycardia Syndrome (POTS), and Brugada Syndrome.